Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 214 articles for trastuzumab

Then save them, add them to a collection or cite them together.
  1. Conference abstract · 18 Oct 2018

    Trastuzumab treatment-related cardiotoxicity: a storm in a teacup?

    Cardiotoxicity (TC) is the most concerning side effect of Trastuzumab. It remains unclear whether the current arbitrary recommendations provide an adequate balance between preventing heart damage and curtailing a…

  2. Article · 10 Nov 2022

    The effectiveness and safety of trastuzumab biosimilar abp 980 plus pertuzumab and docetaxel in the therapy of her2 posi

    Systematic Reviews in Pharmacy · Volume 13, Issue 11

    first- line treatment for HER-2 positive Metastatic Breast Cancers is the combination of trastuzumab, pertuzumab, and taxane (PTH). ABP 980 is a biosimilar of the innovator trastuzumab ... from therapy. Biosimilar ABP…

  3. Review article · 22 Jul 2016

    Trastuzumab in the adjuvant setting: a practical review

    Clinical Practice · Volume 8, Issue 2

    Trastuzumab is a monoclonal antibody directed against the product of the HER2/neu oncogene. The HER2 protein is overexpressed in approximately 20% of human breast cancers and is associated with ... with HER2-positive…

  4. Research article · 15 May 2018

    Inhibition of Erbb2 by Trastuzumab Induces Oxidative Stress Markers in HER2 Positive Breast Cancer Cell Lines

    Journal of Research in Medical and Dental Science · Volume 6, Issue 3

    breast cancers that associated with a faster rate of growth and a poorer prognosis. Trastuzumab is FDA-approved humanized monocholonal antibody that targets the extracellular domain of HER2. In present ... study we…

  5. Research article · 2018

    Combination of Trastuzumab and Radiotherapy in the Adjuvant Treatment of Breast Cancer: A Single Center Experience and Focus on the Cardiac Safety

    Nuclear Medicine & Radiation Therapy · Volume 9, Issue 1

    Background: The main toxicity of trastuzumab, is the alteration of cardiac function. The objective of this study is to examine the acute cardiotoxicity of the combination of Radiotherapy ... trastuzumab in the adjuvant…

  6. Short communication · 10 Dec 2021

    5 year experience of Transthoracic Echocardiographic assessment of left ventricular systolic dysfunction in Hormone receptor positive Breast cancer patients on Trastuzumab therapy

    Research Journal of Congenital Diseases · Volume 4, Issue 1

    Introduction :Trastuzumab has been used as an adjunct to chemotherapy in receptor positive breast cancer patients. However it is known to cause cardiomyopathy with left ventricular systolic dysfunction in about…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels